VR Program for Heart Health Education in Breast Cancer Survivors Undergoing Treatment
A study is underway to evaluate VR program aimed at improving heart health knowledge among breast cancer survivors receiving anthracyclines or trastuzumab.
Company
Pharmaceutical intelligence for pharma companies in oncology with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.